title: Short response duration even in responders to chemotherapy using conventional cytotoxic agents in recurrent or refractory clear cell carcinomas of the ovary.
authors.forename: Masashi
authors.initials: M
authors.lastname: Takano
authors.forename: Tomoko
authors.initials: T
authors.lastname: Goto
authors.forename: Masafumi
authors.initials: M
authors.lastname: Kato
authors.forename: Naoki
authors.initials: N
authors.lastname: Sasaki
authors.forename: Morikazu
authors.initials: M
authors.lastname: Miyamoto
authors.forename: Kenichi
authors.initials: K
authors.lastname: Furuya
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000188:drug therapy*; D002166:Camptothecin / Q000031:analogs & derivatives*; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage*
chemical_list: D043823:Taxoids; D003841:Deoxycytidine; D002166:Camptothecin